.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fuji
Federal Trade Commission
Express Scripts
QuintilesIMS
Cipla
Covington
Dow
Baxter
Merck

Generated: December 17, 2017

DrugPatentWatch Database Preview

DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Dianeal Pd-1 W/ Dextrose 3.5% In Plastic Container patents expire, and when can generic versions of Dianeal Pd-1 W/ Dextrose 3.5% In Plastic Container launch?

Dianeal Pd-1 W/ Dextrose 3.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and seventy drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter HlthcareDIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINERcalcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactateSOLUTION;INTRAPERITONEAL017512-010Nov 18, 1985RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Harvard Business School
Healthtrust
QuintilesIMS
Medtronic
McKesson
Fish and Richardson
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot